SINSIN PHARMACEUTICAL (002800)

Ticker: 002800 Exchange: KOSDAQ


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Kim Sang Kyung (김상경) Unclassified position (상무이사) Director
Transaction date
Purchase
Price
183.54
Quantity 33,003 +35.6%
Value ₩1,683,156
Kim Sang Kyung (김상경) Unclassified position (상무이사) Director
Transaction date
Purchase
Price
139.72
Quantity 49,562 -44.9%
Value ₩3,637,959
Kim Sang Kyung (김상경) Unclassified position (상무이사) Director
Transaction date
Purchase
Price
18.55
Quantity 12,494 +40.1%
Value ₩3,859,748
Kim Sang Kyung (김상경) Unclassified position (상무이사) Director
Transaction date
Purchase
Price
3,275,000.00
Quantity 500 +8.3%
Value ₩1,637,500,000
Kim Sang Kyung (김상경) Unclassified position (상무이사) Director
Transaction date
Purchase
Price
6,396.00
Quantity 500 +16.7%
Value ₩3,198,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2020-02-21 2020-02-20 B Purchase Kim Sang Kyung (김상경)

Unclassified position (상무이사)

Director
33,003 +35.6%
183.54
₩1,683,156
33,003 +35.6% 183.54 ₩1,683,156
2020-02-21 2020-02-19 B Purchase Kim Sang Kyung (김상경)

Unclassified position (상무이사)

Director
49,562 -44.9%
139.72
₩3,637,959
49,562 -44.9% 139.72 ₩3,637,959
2020-02-21 2020-02-17 B Purchase Kim Sang Kyung (김상경)

Unclassified position (상무이사)

Director
12,494 +40.1%
18.55
₩3,859,748
12,494 +40.1% 18.55 ₩3,859,748
2020-02-21 2020-02-12 B Purchase Kim Sang Kyung (김상경)

Unclassified position (상무이사)

Director
500 +8.3%
3,275,000.00
₩1,637,500,000
500 +8.3% 3,275,000.00 ₩1,637,500,000
2017-09-25 2017-09-21 B Purchase Kim Sang Kyung (김상경)

Unclassified position (상무이사)

Director
500 +16.7%
6,396.00
₩3,198,000
500 +16.7% 6,396.00 ₩3,198,000
Explore more

More insider trading research around SINSIN PHARMACEUTICAL